Advertisement
Home 2017

Yearly Archives: 2017

PARP inhibitors demonstrate activity in triple-negative breast cancer tumors without BRCA1/2 mutations

PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors

0
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations
Patients with autoimmune connective tissue diseases (CTDs) undergoing abdominoplasty have increased risk of venous thromboembolism events and need for blood transfusions compared to those without CTDs

Connective Tissue Disease May Raise Post-Abdominoplasty Risks

0
Higher risk of venous thromboembolism, need for blood transfusion for patients with CTD
Systemic inflammation in midlife is associated with future neurodegeneration and cognitive aging

Midlife Systemic Inflammation Tied to Late-Life Brain Volume

0
Smaller hippocampal, Alzheimer's signature region volumes seen 24 years after inflammation noted
Gene replacement therapy is beneficial in spinal muscular atrophy type 1

Gene Replacement Tx Beneficial in Spinal Muscular Atrophy

0
And nusinersen improves motor-milestone response for infants with spinal muscular atrophy
For adolescents with type 1 diabetes and high levels of albumin excretion

ACE Inhibitor, Statin No Benefit for T1DM, High Albumin Excretion

0
Use of ACE inhibitor and a statin does not change albumin-to-creatinine ratio in adolescents with T1DM
Nutritional interventions may be beneficial for the management of chronic kidney disease in adults

Nutritional Therapy Beneficial in Chronic Kidney Disease

0
Management of uremia, electrolyte imbalances, water/salt retention may help increase longevity

Liposuction Can Reduce Lymphedema-Related Swelling

0
Case report describes beneficial effect for three patients with lymphedema affecting the leg or arm
Not all prescription drug users report receiving warnings about driving impairment

Driving Impairment Warnings Often Not Given With Rx Meds

0
For most drug categories, those who do receive warnings perceive higher risk of impaired driving
The central effects of glucagon-like peptide-1 may mediate the effects of Roux-en-Y gastric bypass on central nervous system activation in response to visual and gustatory food cues

GLP-1 May Mediate Effects of Gastric Bypass on CNS Activation

0
After Roux-en-Y, CNS activation reduced in response to food cues, GLP-1 levels significantly elevated
Long-term proton pump inhibitor use is associated with increased risk of gastric cancer even after Helicobacter pylori eradication therapy

PPI-Gastric Cancer Link Remains After H. Pylori Eradication

0
Increased risk seen in H. pylori-infected subjects who received eradication therapy